Jonathan Schechter
Jonathan Schechter's open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price and a…
Insider buying and selling since 2022
Jonathan Schechter bought shares on the open market in 2025 and 2026 across 3 companies. Sales in 1 of the 5 years since 2022.
Jonathan Schechter reported 6 open-market purchases and 1 sale since 2022; purchases in 2 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 3×3 trades | — |
| 2025 | 3×3 trades | — |
| 2022 | — | 1×1 trade |
Insider at 3 companies
- Pharmacyte Biotech PMCB2026 · 3 purchases, 0 sales
- Taoweave TWAV2025 · 3 purchases, 0 sales
- Tao Synergies TAOX2022 · 0 purchases, 1 sale
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about Jonathan Schechter's trades
Has Jonathan Schechter bought shares on the open market?
Jonathan Schechter bought shares on the open market in 2025 and 2026 across 3 companies. Sales in 1 of the 5 years since 2022.
When did Jonathan Schechter last buy or sell shares?
In SEC filings since 2022: the latest open-market purchase is from 2026; the latest open-market sale is from 2022.
Which companies has Jonathan Schechter traded as an insider?
3 companies: Pharmacyte Biotech (PMCB, 2026), Taoweave (TWAV, 2025), Tao Synergies (TAOX, 2022).